Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0N2JI
|
|||
| Former ID |
DIB000799
|
|||
| Drug Name |
VAS-203
|
|||
| Synonyms |
NOS inhibitor, Vasopharm; Nitric oxide synthase inhibitor, Vasopharm
Click to Show/Hide
|
|||
| Indication | Brain injury [ICD-11: NA07.Z] | Phase 2 | [1] | |
| Company |
Vasopharm GmbH
|
|||
| Structure |
 |
Download2D MOL |
||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800023224) | |||
| REF 2 | Nitric oxide synthase inhibition with the antipterin VAS203 improves outcome in moderate and severe traumatic brain injury: a placebo-controlled randomized Phase IIa trial (NOSTRA). J Neurotrauma. 2014 Oct 1;31(19):1599-606. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.